Corrigendum: Safety assessment of poly- ε-caprolactone in the treatment of primary spontaneous pneumothorax

Front Surg. 2024 Feb 29:11:1386747. doi: 10.3389/fsurg.2024.1386747. eCollection 2024.

Cheng-Hung How^#^{1

2}, Pei-Hsing Chen^#^{1

3

4}, Yu-Ching Chen³, Yong-Chong Lin¹, Ke-Cheng Chen⁴, Jin-Shing Chen⁴, Tai-Horng Young¹

¹ Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei City, Taiwan.
² Department of Surgery, Division of Thoracic Surgery, Far Eastern Memorial Hospital, Taipei City, Taiwan.
³ Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
⁴ Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fsurg.2024.1335144.].

Keywords: Phase I trial; pleurodesis; pneumothorax; poly-ε-caprolactone; thoracoscopy.

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article.